vs
安朗杰（ALLE）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
安朗杰的季度营收约是科睿唯安的1.7倍（$1.0B vs $617.0M），安朗杰净利率更高（13.4% vs 0.5%，领先12.9%），安朗杰同比增速更快（9.7% vs -6.9%），过去两年安朗杰的营收复合增速更高（3.5% vs -0.3%）
安朗杰是全球知名的安防产品及解决方案供应商，面向全球生产销售机械与电子类安防产品，包括闭门器、出入口控制设备、锁具、电子门禁系统、考勤与人员效能管理系统、门体系统及相关配件，服务商业、公共机构、住宅等多领域终端用户
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
ALLE vs CLVT — 直观对比
营收规模更大
ALLE
是对方的1.7倍
$617.0M
营收增速更快
ALLE
高出16.7%
-6.9%
净利率更高
ALLE
高出12.9%
0.5%
两年增速更快
ALLE
近两年复合增速
-0.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $617.0M |
| 净利润 | $138.1M | $3.1M |
| 毛利率 | 44.0% | 66.8% |
| 营业利润率 | 18.9% | 6.7% |
| 净利率 | 13.4% | 0.5% |
| 营收同比 | 9.7% | -6.9% |
| 净利润同比 | -6.8% | 101.6% |
| 每股收益（稀释后） | — | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLECLVT
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $617.0M | ||
| Q3 25 | $1.1B | $623.1M | ||
| Q2 25 | $1.0B | $621.4M | ||
| Q1 25 | $941.9M | $593.7M | ||
| Q4 24 | $945.6M | $663.0M | ||
| Q3 24 | $967.1M | $622.2M | ||
| Q2 24 | $965.6M | $650.3M |
净利润ALLECLVT
| Q1 26 | $138.1M | — | ||
| Q4 25 | $147.5M | $3.1M | ||
| Q3 25 | $188.4M | $-28.3M | ||
| Q2 25 | $159.7M | $-72.0M | ||
| Q1 25 | $148.2M | $-103.9M | ||
| Q4 24 | $144.1M | $-191.8M | ||
| Q3 24 | $174.2M | $-65.6M | ||
| Q2 24 | $155.4M | $-304.3M |
毛利率ALLECLVT
| Q1 26 | 44.0% | — | ||
| Q4 25 | 44.5% | 66.8% | ||
| Q3 25 | 45.8% | 65.0% | ||
| Q2 25 | 45.6% | 67.2% | ||
| Q1 25 | 44.9% | 65.1% | ||
| Q4 24 | 44.1% | 65.7% | ||
| Q3 24 | 44.7% | 66.2% | ||
| Q2 24 | 44.4% | 67.2% |
营业利润率ALLECLVT
| Q1 26 | 18.9% | — | ||
| Q4 25 | 20.3% | 6.7% | ||
| Q3 25 | 21.8% | 7.1% | ||
| Q2 25 | 21.5% | 1.1% | ||
| Q1 25 | 20.9% | -3.5% | ||
| Q4 24 | 19.5% | -9.4% | ||
| Q3 24 | 22.2% | 3.5% | ||
| Q2 24 | 21.6% | -36.9% |
净利率ALLECLVT
| Q1 26 | 13.4% | — | ||
| Q4 25 | 14.3% | 0.5% | ||
| Q3 25 | 17.6% | -4.5% | ||
| Q2 25 | 15.6% | -11.6% | ||
| Q1 25 | 15.7% | -17.5% | ||
| Q4 24 | 15.2% | -28.9% | ||
| Q3 24 | 18.0% | -10.5% | ||
| Q2 24 | 16.1% | -46.8% |
每股收益（稀释后）ALLECLVT
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $0.00 | ||
| Q3 25 | $2.18 | $-0.04 | ||
| Q2 25 | $1.85 | $-0.11 | ||
| Q1 25 | $1.71 | $-0.15 | ||
| Q4 24 | $1.65 | $-0.27 | ||
| Q3 24 | $1.99 | $-0.09 | ||
| Q2 24 | $1.77 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $308.9M | $329.2M |
| 总债务越低越好 | $2.0B | $4.3B |
| 股东权益账面价值 | $2.1B | $4.8B |
| 总资产 | $5.3B | $11.1B |
| 负债/权益比越低杠杆越低 | 0.97× | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资ALLECLVT
| Q1 26 | $308.9M | — | ||
| Q4 25 | $356.2M | $329.2M | ||
| Q3 25 | $302.7M | $318.7M | ||
| Q2 25 | $656.8M | $362.6M | ||
| Q1 25 | $494.5M | $354.0M | ||
| Q4 24 | $503.8M | $295.2M | ||
| Q3 24 | $878.9M | $388.5M | ||
| Q2 24 | $747.5M | $376.4M |
总债务ALLECLVT
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $4.3B | ||
| Q3 25 | $2.1B | $4.4B | ||
| Q2 25 | $2.1B | $4.5B | ||
| Q1 25 | $2.0B | $4.5B | ||
| Q4 24 | $2.0B | $4.5B | ||
| Q3 24 | $2.4B | $4.6B | ||
| Q2 24 | $2.4B | $4.6B |
股东权益ALLECLVT
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $4.8B | ||
| Q3 25 | $1.9B | $4.9B | ||
| Q2 25 | $1.8B | $5.0B | ||
| Q1 25 | $1.6B | $5.0B | ||
| Q4 24 | $1.5B | $5.1B | ||
| Q3 24 | $1.6B | $5.5B | ||
| Q2 24 | $1.4B | $5.6B |
总资产ALLECLVT
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.2B | $11.1B | ||
| Q3 25 | $5.2B | $11.2B | ||
| Q2 25 | $4.9B | $11.4B | ||
| Q1 25 | $4.6B | $11.5B | ||
| Q4 24 | $4.5B | $11.5B | ||
| Q3 24 | $5.0B | $12.0B | ||
| Q2 24 | $4.8B | $12.1B |
负债/权益比ALLECLVT
| Q1 26 | 0.97× | — | ||
| Q4 25 | 0.96× | 0.89× | ||
| Q3 25 | 1.07× | 0.90× | ||
| Q2 25 | 1.16× | 0.90× | ||
| Q1 25 | 1.24× | 0.90× | ||
| Q4 24 | 1.33× | 0.88× | ||
| Q3 24 | 1.53× | 0.84× | ||
| Q2 24 | 1.69× | 0.83× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $101.3M | $159.9M |
| 自由现金流经营现金流 - 资本支出 | — | $89.2M |
| 自由现金流率自由现金流/营收 | — | 14.5% |
| 资本支出强度资本支出/营收 | 2.0% | 11.5% |
| 现金转化率经营现金流/净利润 | 0.73× | 51.58× |
| 过去12个月自由现金流最近4个季度 | — | $365.3M |
8季度趋势，按日历期对齐
经营现金流ALLECLVT
| Q1 26 | $101.3M | — | ||
| Q4 25 | $240.1M | $159.9M | ||
| Q3 25 | $229.5M | $181.1M | ||
| Q2 25 | $209.7M | $116.3M | ||
| Q1 25 | $104.5M | $171.2M | ||
| Q4 24 | $219.0M | $141.3M | ||
| Q3 24 | $231.9M | $202.9M | ||
| Q2 24 | $173.0M | $126.2M |
自由现金流ALLECLVT
| Q1 26 | — | — | ||
| Q4 25 | $200.5M | $89.2M | ||
| Q3 25 | $209.8M | $115.5M | ||
| Q2 25 | $192.0M | $50.3M | ||
| Q1 25 | $83.4M | $110.3M | ||
| Q4 24 | $194.9M | $59.1M | ||
| Q3 24 | $212.0M | $126.3M | ||
| Q2 24 | $152.1M | $60.3M |
自由现金流率ALLECLVT
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 14.5% | ||
| Q3 25 | 19.6% | 18.5% | ||
| Q2 25 | 18.8% | 8.1% | ||
| Q1 25 | 8.9% | 18.6% | ||
| Q4 24 | 20.6% | 8.9% | ||
| Q3 24 | 21.9% | 20.3% | ||
| Q2 24 | 15.8% | 9.3% |
资本支出强度ALLECLVT
| Q1 26 | 2.0% | — | ||
| Q4 25 | 3.8% | 11.5% | ||
| Q3 25 | 1.8% | 10.5% | ||
| Q2 25 | 1.7% | 10.6% | ||
| Q1 25 | 2.2% | 10.3% | ||
| Q4 24 | 2.5% | 12.4% | ||
| Q3 24 | 2.1% | 12.3% | ||
| Q2 24 | 2.2% | 10.1% |
现金转化率ALLECLVT
| Q1 26 | 0.73× | — | ||
| Q4 25 | 1.63× | 51.58× | ||
| Q3 25 | 1.22× | — | ||
| Q2 25 | 1.31× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | 1.52× | — | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
